Chang-Xian Li Selected Research

Inflammation (Inflammations)

1/2023

Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Xian Li Research Topics

Disease

5	Neoplasms (Cancer) 11/2017 - 11/2006
3	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2012
2	Reperfusion Injury 01/2023 - 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Death (Near-Death Experience) 11/2017
1	Blister (Bulla) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Fatty Liver 12/2014
1	Ischemia 12/2014
1	Lung Neoplasms (Lung Cancer) 07/2012
1	Brain Neoplasms (Brain Tumor) 07/2012
1	Cholangiocarcinoma 11/2006

Drug/Important Bio-Agent (IBA)

1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023
1	HDL LipoproteinsIBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	CollagenIBA 01/2017
1	Endoplasmic Reticulum Chaperone BiPIBA 09/2015
1	Cisplatin (Platino)FDA LinkGeneric 09/2015
1	Chemokine CXCL10IBA 12/2014
1	Lipocalin-2IBA 12/2014
1	erucylphosphocholineIBA 01/2014
1	gadobutrolIBA 07/2012
1	gadobenic acid (gadobenate dimeglumine)FDA Link 07/2012
1	GadoliniumIBA 11/2006
1	BismuthIBA 11/2006

Therapy/Procedure

5	Liver Transplantation 11/2017 - 01/2014
1	Aftercare (After-Treatment) 01/2017
1	Drug Therapy (Chemotherapy) 09/2015
1	Hepatectomy 12/2014
1	Transplantation 01/2014